ABP1011T Tablets

· Shanghai AB PharmaTech Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABP1011T Tablets, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors [Phase 2]